BigClassActions.com

Roka Bioscience Inc. ROKA Securities Lawsuit

- by

Company: Roka Bioscience Inc.
Ticker Symbol: ROKA
Class Period: Jul-17-14 to Nov-6-14
Date Filed: Jan-7-15
Lead Plaintiff Deadline: Mar-8-15
Court: District of New Jersey
Allegations:
Los Angeles, CA: A securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Roka Bioscience Inc. ("Roka"or the "Company") (Nasdaq: ROKA) securities pursuant or traceable to the Company' initial public offering which commenced on or about July 17 2014 (the "IPO"or "Offering") including those who purchased or otherwise acquired Roka common stock between July 17 2014 and November 6 2014 inclusive (the "Class Period"). Investors who wish to become proactively involved in the litigation have until February 23 2015 to seek appointment as lead plaintiff.

The complaint accuses the defendants of violations of the Securities Act of 1933 by virtue of Roka' failure to disclose in the Offering documents known trends and uncertainties about the demand for its Atlas instrument used to detect foodborne pathogens. According to the complaint after the Company' November 6 2014 announcement that in the third quarter of 2014 it had not placed any Atlas instruments in the marketplace and suffered an unexpected loss for the quarter the value of Atlas shares declined significantly.



If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Roka Bioscience Inc. ROKA Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Roka Bioscience Inc. securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help